Home > Income Statement > BETA DRUGS
COMMUNITY POLL
for BETA DRUGS
Please provide your vote to see the results

BETA DRUGS Last 5 Year Revenue History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Net Sales ₹362 Cr₹296 Cr₹227 Cr₹184 Cr₹116 Cr

What is the latest Revenue of BETA DRUGS ?

The latest Revenue ratio of BETA DRUGS is ₹362 Cr based on Mar2025 Consolidated results.
Year Revenue
Mar2025₹362 Cr
Mar2024₹296 Cr
Mar2023₹227 Cr
Mar2022₹184 Cr
Mar2021₹116 Cr

How is Revenue of BETA DRUGS Trending?

Years Revenue % Change
Mar2025 ₹362 Cr
22.54
Mar2024 ₹296 Cr
30.21
Mar2023 ₹227 Cr
23.54
Mar2022 ₹184 Cr
58.31
Mar2021 ₹116 Cr -

Compare Revenue of peers of BETA DRUGS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
BETA DRUGS ₹2,477.4 Cr 0.1% 3.5% 29.7% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹477,312.0 Cr 0.8% 6.3% 18.2% Stock Analytics
DIVIS LABORATORIES ₹213,879.0 Cr 8.6% 20.7% 18.5% Stock Analytics
TORRENT PHARMACEUTICALS ₹194,094.0 Cr 1.7% 9.4% 38.5% Stock Analytics
CIPLA ₹118,992.0 Cr 4.5% 1.2% -1.4% Stock Analytics
DR REDDYS LABORATORIES ₹95,787.4 Cr -0.3% -14.8% -9.5% Stock Analytics


BETA DRUGS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
BETA DRUGS

0.1%

3.5%

29.7%

SENSEX

2.7%

1.5%

-5.6%


You may also like the below Video Courses